相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Pharmacokinetic Standard for Babies and Adults
Nick Holford et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development-Part 2: Introduction to Pharmacokinetic Modeling Methods
Dr Mould et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Motor Complications in Parkinson's Disease: Ten Year Follow-Up Study
Iria Cabo Lopez et al.
MOVEMENT DISORDERS (2010)
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa
Robert A. Hauser et al.
MOVEMENT DISORDERS (2007)
Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide
Karl Brendel et al.
PHARMACEUTICAL RESEARCH (2006)
Sydney multicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years
MA Hely et al.
MOVEMENT DISORDERS (2005)
Clinical-pathological study of levodopa complications
AH Rajput et al.
MOVEMENT DISORDERS (2002)
Levodopa pharmacokinetic-pharmacodynamic modeling and 6-[18F]levodopa positron emission tomography in patients with Parkinson's disease
M Dietz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Dyskinesias and motor fluctuations in Parkinson's disease - A community-based study
A Schrag et al.
BRAIN (2000)
Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcapone
K Jorga et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
